瑞士生物技术协会：2026瑞士生物技术报告：人才储备与产业韧性（英文版）（64页）.pdf

1、Scan the QR code to download the Swiss Biotech Report 2026ImpressumSteering CommitteeMichael Altorfer,Swiss Biotech AssociationFlorian Fisch,Swiss National Science FoundationJan Lucht,scienceindustriesHans-Peter Meyer,SATWChristian Moser Nikles,Swiss Federal Institute of Intellectual PropertyJrg Sch

2、lpfer,SwissmedicFrederik Schmachtenberg,EYSirpa Tsimal,Switzerland Global EnterpriseProject lead Corinne Goetschel|CGCConcept and DesignRichard Hayhurst&Janet Joy|RHA CommunicationsEd Gover|Conscience Creative PartnershipPrinterSchmid-Fehr AGTalent and Tenacity“Switzerlands future depends on an ecos

3、ystem that invests in talent,rewards determination,supports entrepreneurial freedom,and thrives through international collaboration.Its competitive edge lies in its people:focused on developing solutions for global challenges and building international alliances.”Michael Altorfer Swiss Biotech Assoc

4、iation“In 2025 Swiss biotech companies recorded record revenues of CHF 7.5 billion,while R&D investments remained at a very high level(CHF 2.5 billion).Overall financing was 2%up on the previous year,and privately funded companies raised a record CHF 1.15 billion.This represents an increase of 38%co

5、mpared to 2024,and a record 45%relative share of the total funding pot.”Frederik Schmachtenberg EY“Talent is the foundation of regulatory credibility.By investing in people,fostering collaboration across disciplines and borders,and maintaining a clear commitment to scientific rigor and independence,

6、Swissmedic strengthens the trust placed in regulatory decisions.”Jrg Schlpfer Swissmedic“Over the past twenty-five years,the chemical,pharma,and life science industries have been responsible for 72%of Switzerlands total export growth.In 2025,they accounted for 53%of Swiss exports;the immunologicals